Terms: = Kidney tumors AND BCL9, LGS, 607, ENSG00000116128, MGC131591
42 results:
1. Outcome benefits of upfront cytoreductive nephrectomy for patients with metastatic renal cell carcinoma: An analysis of the TriNetX database.
Lai GS; Li JR; Wang SS; Chen CS; Yang CK; Lin CY; Hung SC; Chiu KY; Yang SF
PLoS One; 2024; 19(3):e0299102. PubMed ID: 38547226
[TBL] [Abstract] [Full Text] [Related]
2. Clinical application of vancomycin TDM in ventilated patients with gastrointestinal cancer: a propensity-matched analysis.
Zhang X; Wu Y; Wang D
BMC Infect Dis; 2024 Jan; 24(1):10. PubMed ID: 38166695
[TBL] [Abstract] [Full Text] [Related]
3. Investigating the prognostic role of lncRNAs associated with disulfidptosis-related genes in clear cell renal cell carcinoma.
Sun Z; Wang J; Fan Z; Yang Y; Meng X; Ma Z; Niu J; Guo R; Tran LJ; Zhang J; Jiang T; Liu Y; Yang Q; Ma B
J Gene Med; 2024 Jan; 26(1):e3608. PubMed ID: 37897262
[TBL] [Abstract] [Full Text] [Related]
4. Role of ultra-high b-value DWI in the imaging of hereditary leiomyomatosis and renal cell carcinoma (HLRCC).
Chaurasia A; Gopal N; Dehghani Firouzabadi F; Yazdian Anari P; Wakim P; Ball MW; Jones EC; Turkbey B; Huda F; Linehan WM; Turkbey EB; Malayeri AA
Abdom Radiol (NY); 2023 Jan; 48(1):340-349. PubMed ID: 36207629
[TBL] [Abstract] [Full Text] [Related]
5. A risk signature based on necroptotic-process-related genes predicts prognosis and immune therapy response in kidney cell carcinoma.
Li J; Liu X; Qi Y; Liu Y; Du E; Zhang Z
Front Immunol; 2022; 13():922929. PubMed ID: 36189275
[TBL] [Abstract] [Full Text] [Related]
6. Integrated Analysis of the lncRNA-Associated ceRNA Network in Wilms Tumor via TARGET and GEO Databases.
An B; Hu Y; Liang X
Genet Res (Camb); 2022; 2022():2365991. PubMed ID: 36101743
[TBL] [Abstract] [Full Text] [Related]
7. Cost Effectiveness Analysis of Radiofrequency Ablation (RFA) Versus Stereotactic Body Radiotherapy (SBRT) for Early Stage Renal Cell Carcinoma (RCC).
Donovan EK; Xie F; Louie AV; Chu W; Siva S; Kapoor A; Swaminath A
Clin Genitourin Cancer; 2022 Oct; 20(5):e353-e361. PubMed ID: 35490099
[TBL] [Abstract] [Full Text] [Related]
8. Primary Sjögren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis.
Zhong H; Liu S; Wang Y; Xu D; Li M; Zhao Y; Zeng X
Autoimmun Rev; 2022 May; 21(5):103084. PubMed ID: 35341972
[TBL] [Abstract] [Full Text] [Related]
9. LINC00467 Is Upregulated by DNA Copy Number Amplification and Hypomethylation and Shows ceRNA Potential in Lung Adenocarcinoma.
Wang W; Bo H; Liang Y; Li G
Front Endocrinol (Lausanne); 2021; 12():802463. PubMed ID: 35095769
[TBL] [Abstract] [Full Text] [Related]
10. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis.
Psutka SP; Gulati R; Jewett MAS; Fadaak K; Finelli A; Legere L; Morgan TM; Pierorazio PM; Allaf ME; Herrin J; Lohse CM; Houston Thompson R; Boorjian SA; Atwell TD; Schmit GD; Costello BA; Shah ND; Leibovich BC
Eur Urol; 2022 Jun; 81(6):576-585. PubMed ID: 34862099
[TBL] [Abstract] [Full Text] [Related]
11. Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma.
Nemoto Y; Ishihara H; Nakamura K; Tachibana H; Fukuda H; Yoshida K; Kobayashi H; Iizuka J; Shimmura H; Hashimoto Y; Tanabe K; Kondo T; Takagi T
Int Urol Nephrol; 2022 Jan; 54(1):47-54. PubMed ID: 34704214
[TBL] [Abstract] [Full Text] [Related]
12. Cardiac, Hepatic and Renal Dysfunction and IL-18 Polymorphism in Breast, Colorectal, and Prostate Cancer Patients.
Qader G; Aali M; Smail SW; Mahmood K; Hasan B; M-Amen K; Rahman DB; Qadir FA; Mohammad DK; Najmuldeen HH; Rahman FM; Ahmad SI; Salih NS; Khdhr ZM; Mohammed BA; Majeed AM; Hasan XM; Khidhir BH; Muhammad ES; Muhamadsalih BA; Hasan SK; Hamad AJ; Esmail ZK; Ismael CM; Husaen SM; Abdulla CA; Hussen BM; Housein Z; Shekha M; Salihi A
Asian Pac J Cancer Prev; 2021 Jan; 22(1):131-137. PubMed ID: 33507690
[TBL] [Abstract] [Full Text] [Related]
13. Fine Particulate Matter Exposure and Cancer Incidence: Analysis of SEER Cancer Registry Data from 1992-2016.
Coleman NC; Burnett RT; Ezzati M; Marshall JD; Robinson AL; Pope CA
Environ Health Perspect; 2020 Oct; 128(10):107004. PubMed ID: 33035119
[TBL] [Abstract] [Full Text] [Related]
14. A Multi-Institutional Analysis of the Effect of Positive Surgical Margins Following Robot-Assisted Partial Nephrectomy on Oncologic Outcomes.
Rothberg MB; Paulucci DJ; Okhawere KE; Reynolds CR; Badani KK; Abaza R; Eun D; Bhandari A; Porter J; Hemal AK
J Endourol; 2020 Mar; 34(3):304-311. PubMed ID: 31931607
[No Abstract] [Full Text] [Related]
15. Contribution of Inflammatory Cytokine Interleukin-18 Genotypes to Renal Cell Carcinoma.
Chang WS; Shen TC; Yeh WL; Yu CC; Lin HY; Wu HC; Tsai CW; Bau DT
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925760
[TBL] [Abstract] [Full Text] [Related]
16. Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial.
Fuchs CS; Shitara K; Di Bartolomeo M; Lonardi S; Al-Batran SE; Van Cutsem E; Ilson DH; Alsina M; Chau I; Lacy J; Ducreux M; Mendez GA; Alavez AM; Takahari D; Mansoor W; Enzinger PC; Gorbounova V; Wainberg ZA; Hegewisch-Becker S; Ferry D; Lin J; Carlesi R; Das M; Shah MA;
Lancet Oncol; 2019 Mar; 20(3):420-435. PubMed ID: 30718072
[TBL] [Abstract] [Full Text] [Related]
17. Preoperative apolipoprotein B/A1 ratio is an independent prognostic factor in metastatic renal cell carcinoma.
Zhang F; Xie Y; Ma X; Gu L; Li H; Li X; Guo G; Zhang X
Urol Oncol; 2019 Mar; 37(3):184.e9-184.e17. PubMed ID: 30509867
[TBL] [Abstract] [Full Text] [Related]
18. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.
Wang Y; Zhang C; Zhang P; Guo G; Jiang T; Zhao X; Jiang J; Huang X; Tong H; Tian Y
Cancer Med; 2018 May; 7(5):1670-1679. PubMed ID: 29573235
[TBL] [Abstract] [Full Text] [Related]
19. Obesity surgery and risk of colorectal and other obesity-related cancers: An English population-based cohort study.
Aravani A; Downing A; Thomas JD; Lagergren J; Morris EJA; Hull MA
Cancer Epidemiol; 2018 Apr; 53():99-104. PubMed ID: 29414638
[TBL] [Abstract] [Full Text] [Related]
20. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery.
Leibovich BC; Lohse CM; Cheville JC; Zaid HB; Boorjian SA; Frank I; Thompson RH; Parker WP
Eur Urol; 2018 May; 73(5):772-780. PubMed ID: 29398265
[TBL] [Abstract] [Full Text] [Related]
[Next]
